Worth reading
59In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the 11th Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions)
Who receives how much
Number of shares delivered during the applicable month: — shares. New shares: — shares; treasury shares transferred: — shares
EVO FUND (allottee of the 11th Series Stock Acquisition Rights)
The lower thin line represents the existing number of shares to which these shares will be added.
発行済株式総数
Exercise ratio subject to exercise restrictions: —%. Exercise ratio during the applicable month: —%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price during the applicable month: ¥195. Details of the adjustment provisions are not disclosed in this document.
Number of Stock Acquisition Rights
Total number issued: 104,596. Number unexercised as of the end of the month preceding the applicable month: 92,000; number unexercised as of the end of the applicable month: 92,000
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Timing 12 February 2026 / Type 11th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 11th Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions) |
| Number of shares to be issued or disposed of | Number of shares delivered during the applicable month: — shares. New shares: — shares; treasury shares transferred: — shares |
| Intended allottee | EVO FUND (allottee of the 11th Series Stock Acquisition Rights) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: —%. Exercise ratio during the applicable month: —% |
| Total number of issued shares | 16,101,892 shares (as of the end of the month preceding the applicable month; including 203,957 treasury shares) → Not disclosed |
| Exercise price | Exercise price during the applicable month: ¥195. Details of the adjustment provisions are not disclosed in this document. |
| Number of Stock Acquisition Rights | Total number issued: 104,596. Number unexercised as of the end of the month preceding the applicable month: 92,000; number unexercised as of the end of the applicable month: 92,000 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 12 February 2026 / Type 11th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions) / Amount Not disclosed |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company has not disclosed the reason why the stock acquisition rights were not exercised.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.